ACTG1
Basic information
Region (hg38): 17:81509413-81523847
Previous symbols: [ "ACTG", "DFNA20", "DFNA26" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant nonsyndromic hearing loss 20 (Strong), mode of inheritance: AD
- Baraitser-winter syndrome 2 (Strong), mode of inheritance: AD
- Baraitser-Winter cerebrofrontofacial syndrome (Supportive), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
- Baraitser-winter syndrome 2 (Definitive), mode of inheritance: AD
- Baraitser-winter syndrome 2 (Strong), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss 20 (Strong), mode of inheritance: AD
- Baraitser-winter syndrome 2 (Definitive), mode of inheritance: AD
- nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Baraitser-Winter syndrome 2 | AD | Audiologic/Otolaryngologic; Cardiovascular | Though the condition may be recognizable, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Individuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management | Audiologic/Otolaryngologic;Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 5654493; 3351890; 12519370; 14684684; 13680526; 16773128; 19477959; 22366783; 25052316 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (6 variants)
- Autosomal dominant nonsyndromic hearing loss 20 (6 variants)
- Baraitser-winter syndrome 2 (4 variants)
- Nonsyndromic genetic hearing loss (1 variants)
- Lissencephaly (1 variants)
- Autosomal dominant nonsyndromic hearing loss 20;Baraitser-winter syndrome 2 (1 variants)
- Baraitser-winter syndrome 2;Autosomal dominant nonsyndromic hearing loss 20 (1 variants)
- Microcephaly (1 variants)
- Inborn genetic diseases (1 variants)
- Congenital anomaly of kidney and urinary tract (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACTG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 197 | 13 | 214 | |||
missense | 11 | 35 | 93 | 141 | ||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 26 | 2 | 32 | ||
non coding | 76 | 44 | 124 | |||
Total | 11 | 37 | 110 | 275 | 57 |
Variants in ACTG1
This is a list of pathogenic ClinVar variants found in the ACTG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-81510406-T-C | Benign (Jun 26, 2018) | |||
17-81510431-G-A | Likely benign (Dec 07, 2019) | |||
17-81510463-G-A | Likely benign (Jul 15, 2018) | |||
17-81510491-T-A | Benign (Jan 29, 2020) | |||
17-81510496-T-G | Likely benign (Jun 04, 2020) | |||
17-81510498-C-G | Benign (Jun 14, 2018) | |||
17-81510544-T-C | Benign (Jan 06, 2020) | |||
17-81510547-C-G | Benign (Jan 06, 2020) | |||
17-81510556-G-A | Likely benign (Aug 03, 2018) | |||
17-81510560-C-T | Likely benign (Feb 17, 2021) | |||
17-81510562-A-C | Benign (Feb 13, 2020) | |||
17-81510564-G-C | Benign (Jan 29, 2020) | |||
17-81510578-G-A | Likely benign (Jun 28, 2018) | |||
17-81510658-T-C | Benign (Jan 22, 2020) | |||
17-81510672-C-T | not specified | Likely benign (Sep 06, 2016) | ||
17-81510679-G-A | not specified | Uncertain significance (Nov 05, 2015) | ||
17-81510684-G-C | Likely benign (Aug 05, 2020) | |||
17-81510688-G-A | ACTG1-related disorder | Benign (Feb 25, 2020) | ||
17-81510690-T-C | not specified • Baraitser-winter syndrome 2;Autosomal dominant nonsyndromic hearing loss 20 • Autosomal dominant nonsyndromic hearing loss 20 • Baraitser-winter syndrome 2 | Benign (Feb 01, 2024) | ||
17-81510696-G-A | Baraitser-winter syndrome 2;Autosomal dominant nonsyndromic hearing loss 20 | Likely benign (Aug 22, 2022) | ||
17-81510697-C-T | Autosomal dominant nonsyndromic hearing loss 20;Baraitser-winter syndrome 2 | Uncertain significance (Nov 28, 2022) | ||
17-81510699-T-C | ACTG1-related disorder | Likely benign (Apr 27, 2022) | ||
17-81510705-G-A | not specified • Autosomal dominant nonsyndromic hearing loss 20;Baraitser-winter syndrome 2 • Autosomal dominant nonsyndromic hearing loss 20 • Baraitser-winter syndrome 2 | Benign (Jan 22, 2024) | ||
17-81510708-G-A | Baraitser-winter syndrome 2;Autosomal dominant nonsyndromic hearing loss 20 | Likely benign (Oct 24, 2022) | ||
17-81510708-G-T | not specified • Autosomal dominant nonsyndromic hearing loss 20;Baraitser-winter syndrome 2 | Likely benign (May 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACTG1 | protein_coding | protein_coding | ENST00000575842 | 5 | 13877 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00478 | 0.969 | 125738 | 0 | 7 | 125745 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.16 | 72 | 197 | 0.366 | 0.0000101 | 2431 |
Missense in Polyphen | 49 | 124.26 | 0.39435 | 1569 | ||
Synonymous | -19.0 | 291 | 78.0 | 3.73 | 0.00000434 | 746 |
Loss of Function | 1.95 | 6 | 13.8 | 0.435 | 6.16e-7 | 151 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. {ECO:0000305|PubMed:29581253}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959, ECO:0000269|PubMed:22938506, ECO:0000269|PubMed:25388789}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in ACTG1 has been found in a patient with isolated coloboma, a defect of the eye characterized by the absence of ocular structures due to abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). Isolated colobomas may be associated with an abnormally small eye (microphthalmia) or small cornea. {ECO:0000269|PubMed:28493397}.;
- Pathway
- Platelet activation - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Oxytocin signaling pathway - Homo sapiens (human);Salmonella infection - Homo sapiens (human);Adherens junction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Viral myocarditis - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Tight junction - Homo sapiens (human);Influenza A - Homo sapiens (human);Phagosome - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Shigellosis - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Apoptosis - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy;Pathogenic Escherichia coli infection;Common Pathways Underlying Drug Addiction;Myometrial Relaxation and Contraction Pathways;Focal Adhesion;Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation;Striated Muscle Contraction;Regulation of Actin Cytoskeleton;Developmental Biology;Signal Transduction;Fcgamma receptor (FCGR) dependent phagocytosis;EPH-Ephrin signaling;Innate Immune System;Immune System;EPHB-mediated forward signaling;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate Formins;RHO GTPase Effectors;Signaling by Rho GTPases;Regulation of actin dynamics for phagocytic cup formation;Axon guidance
(Consensus)
Intolerance Scores
- loftool
- 0.0321
- rvis_EVS
- -1.93
- rvis_percentile_EVS
- 1.91
Haploinsufficiency Scores
- pHI
- 0.930
- hipred
- Y
- hipred_score
- 0.711
- ghis
- 0.631
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.970
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Actg1
- Phenotype
- hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); muscle phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- retina homeostasis;cell junction assembly;Fc-gamma receptor signaling pathway involved in phagocytosis;sarcomere organization;ephrin receptor signaling pathway;synaptic vesicle endocytosis;membrane organization;platelet aggregation;cellular response to interferon-gamma
- Cellular component
- extracellular space;nucleus;cytosol;cytoskeleton;actin filament;plasma membrane;focal adhesion;membrane;myofibril;filamentous actin;myelin sheath;calyx of Held;phagocytic vesicle;extracellular exosome;blood microparticle;dense body;Schaffer collateral - CA1 synapse
- Molecular function
- structural constituent of cytoskeleton;protein binding;profilin binding;ATP binding;ubiquitin protein ligase binding;identical protein binding